New Dual-Drug injection shows promise in major weight loss trial
NCT ID NCT06388187
Summary
This study is testing a new weekly injection called CagriSema to see how well it helps people with obesity lose weight. About 300 adults will receive either the real injection or a placebo (dummy medicine) for about a year and a half. The main goal is to measure how much body weight participants lose and how many achieve significant weight reduction.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Accellacare
Wilmington, North Carolina, 28401, United States
-
Addenbrooke's Hospital_Cambridge
Cambridge, CB2 0QQ, United Kingdom
-
AmBeNet GmbH
Leipzig, 04107, Germany
-
Aurora FDRC Inc.
Costa Mesa, California, 92627, United States
-
Capital Clin Res Ctr,LLC
Olympia, Washington, 98502, United States
-
Centre Hospitalier Universitaire de Nantes-Hopital Nord Laennec
Saint-Herblain, 44800, France
-
Centre Hospitalier Universitaire de Toulouse-Hopital Rangueil
Toulouse, 31059, France
-
Clinical Trial Res Assoc,Inc
Plantation, Florida, 33324, United States
-
Forschungszentrum Ruhr KliFoCenter GmbH, Kahrmann
Witten, 58455, Germany
-
Hospices Civils de Lyon-Hopital Lyon Sud
Pierre-Bénite, 69310, France
-
Hospices Civils de Lyon-Hopital Lyon Sud-1
Pierre-Bénite, 69310, France
-
InnoDiab Forschung GmbH
Essen, 45136, Germany
-
Institut für Diabetesforschung GmbH Münster - Dr. med. Rose
Münster, 48145, Germany
-
Joint Clinical Research Facility - Swansea
Swansea, SA2 8PP, United Kingdom
-
Midwest Inst For Clin Res
Indianapolis, Indiana, 46260, United States
-
Nova Scotia Health Authority
Halifax, Nova Scotia, B3H 1V7, Canada
-
Ocean West Research Clinic
Surrey, British Columbia, V3Z 2N6, Canada
-
Southmead Hospital
Bristol, BS10 5NB, United Kingdom
-
Staploe Medical Centre
Soham, CB7 5JD, United Kingdom
-
The Health Centre
Bradford-on-Avon, BA15 1DQ, United Kingdom
-
University Hospital Coventry - WISDEM Centre
Coventry, CV2 2DX, United Kingdom
-
Velocity Clinical Res-Dallas
Dallas, Texas, 75230, United States
-
Washington Cntr Weight Mgmt
Arlington, Virginia, 22206, United States
-
Wendisch - Dahl Hamburg - DZHW
Hamburg, 22607, Germany
-
Wharton Med Clin Trials
Hamilton, Ontario, L8L 5G8, Canada
Conditions
Explore the condition pages connected to this study.